Home/BellaSeno/Dr. Thomas Lingner

DT

Dr. Thomas Lingner

Chief Technology Officer

Therapeutic Areas

Breast Reconstruction Chest-Wall Defects Trauma & Orthopedics

BellaSeno Pipeline

Drug	Indication	Phase
Breast Scaffold	Breast Reconstruction/Augmentation	Clinical Trial
Pectus Scaffold	Chest-Wall Defects (Pectus)	Clinical Trial
Bone Scaffold	Trauma & Orthopedic Bone Defects	Pre-clinical/Development

Leadership Team at BellaSeno

Dr. Mohit P. Chhaya

Chief Executive Officer (CEO) / Co-Founder

Dr. med. Tobias Grossner

Chief Medical Officer (CMO)

Sanat Dimetriou-Dickson

Chief Marketing Officer

Herbert Stadler, PhD

Chairman Supervisory Board / Investor

View full BellaSeno profile